Patel Sanj K 4

4 · Kiniksa Pharmaceuticals International, plc · Filed Apr 3, 2026

AI-generated summary of this filing

Updated Apr 3, 2026

Kiniksa (KNSA) CEO Sanj Patel Exercises Options, Shares Sold for Taxes

What Happened

Sanj K. Patel, Chairman & CEO of Kiniksa Pharmaceuticals (KNSA), had multiple equity events dated April 1, 2026: conversions/exercises of derivative awards totaling 42,654 shares and new grants/awards of 210,300 restricted/performance units. To satisfy tax/exercise obligations, 10,313 shares were surrendered/disposed at $48.13 each for proceeds of $496,365 (transaction code F = payment of exercise price or tax liability).

Key Details

Transaction date (all): April 1, 2026; Form 4 filed April 3, 2026 (appears timely).
Derivative conversions/exercises (code M): total 42,654 shares (individual line items: 21,327; 6,481; 6,237; 8,609).
Awards/grants (code A): RSUs/PSUs totaling 210,300 units (120,150; 60,100; 30,050) with $0 per-unit acquisition price.
Tax withholding/payment (code F): 10,313 shares disposed at $48.13 = $496,365.
Shares owned after transaction: not specified in the provided filing data.
Notable footnotes:
- RSUs: each RSU = contingent right to 1 Class A Ordinary Share (F1); RSU grants vest ratably over four years with 25% vesting on grant anniversaries (F3, F6–F8).
- PSUs: each PSU converts to up to 200% of one share based on performance, with final conversion no later than Jan 30, 2029 (F4, F5).
- Option vesting schedule (if applicable): 25% on first anniversary, then monthly over 36 months; vesting commencement date April 1, 2026 (F2).

Context

The filing shows awards and derivative conversions alongside a share surrender to cover taxes/withholding — a routine administrative step (code F) rather than an open-market sale. Derivative entries (M) indicate exercises/conversions of vested awards; award entries (A) reflect new RSU/PSU grants. These items are common forms of executive compensation and do not necessarily indicate a change in the executive’s view of the company.

Form 4

Period: 2026-04-01

DirectorCHAIRMAN & CEO

Transactions

Exercise/Conversion
Class A Ordinary Share
[F1]
2026-04-01+21,327→ 81,327 total(indirect: By Trust)
Tax Payment
Class A Ordinary Share
2026-04-01$48.13/sh−10,313$496,365→ 71,014 total(indirect: By Trust)
Award
Share Option
[F2]
2026-04-01+120,150→ 120,150 total
Exercise: $48.13Exp: 2036-03-31→ Class A Ordinary Share (120,150 underlying)
Award
Restricted Share Unit
[F1][F3]
2026-04-01+30,050→ 30,050 total
→ Class A Ordinary Share (30,050 underlying)
Award
Performance Share Unit
[F4][F5]
2026-04-01+60,100→ 60,100 total
→ Class A Ordinary Share (60,100 underlying)
Exercise/Conversion
Restricted Share Unit
[F1][F6]
2026-04-01−6,481→ 6,481 total
→ Class A Ordinary Share (6,481 underlying)
Exercise/Conversion
Restricted Share Unit
[F1][F7]
2026-04-01−6,237→ 12,475 total
→ Class A Ordinary Share (6,237 underlying)
Exercise/Conversion
Restricted Share Unit
[F1][F8]
2026-04-01−8,609→ 25,826 total
→ Class A Ordinary Share (8,609 underlying)

Holdings

Footnotes (8)

[F1]Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.
[F2]The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 1, 2026.
[F3]The RSUs vest over a four-year period, with 25% of the RSUs vesting on the vesting commencement date of April 1, 2026, and each yearly anniversary thereafter.
[F4]Each Performance Share Unit (PSU) represents a contingent right to receive a number of Class A Ordinary Shares of the Issuer based upon the achievement of certain pre-established performance criteria, as certified by the Issuer's Compensation Committee.
[F5]Unless earlier forfeited, each PSU vests and converts into not more than 200% of one Class A Ordinary Share of the Issuer no later than January 30, 2029, unless such date falls on a non-business date, in which case the next business date shall apply.
[F6]The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2023.
[F7]The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2024.
[F8]The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2025.

Signature

/s/ Douglas Barry, Attorney-in-Fact|2026-04-03

1 file